Impact Factor: 0.94*
Journal of Biomarkers in Drug Development is an open access, peer-reviewed, bi-annual, online journal that aims to promote the exchange of original knowledge and research in any area of ethnomedicine.
Journal of Biomarkers in Drug Development invites research articles and reviews based on original interdisciplinary studies on the inextricable relationships between human cultures and nature/universe, Traditional Environmental/Ecological Knowledge (TEK), folk and traditional medical knowledge, as well as the relevance of these for environmental and public health policies.
Specifically, the journal will cover the following topics: ethnobotany, ethnomycology, ethnozoology, ethnoecology (including ethnopedology), ethnometereology/ ethnoclimatology, ethnoastronomy, ethnopharmacy, ethnomedicine, ethnoveterinary, traditional medicines, traditional healthcare in households and domestic arenas, migrant healthcare/urban ethnobiology, pluralistic healthcare in developing countries, evidence-based community health, visual ethnobiology and ethnomedicine, gender studies and ethnobiology, as well as other related areas in environmental, nutritional, medical and visual anthropology. Botanically-centered manuscripts must clearly indicate voucher specimens and herbaria.
Submit manuscript Online or send us an e-mail attachment to the Editorial Office at [email protected]
*2021 Journal Impact Factor was established by dividing the number of articles published in 2019 and 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If 'X' is the total number of articles published in 2019 and 2020, and 'Y' is the number of times these articles were cited in indexed journals during 2021 then, impact factor = Y/X
Author(s): Lanctot Marotta*
The technology of massively parallel or deep sequencing, known as next generation sequencing (NGS), has transformed genomic research. Next-generation sequencing, in comparison to first-generation sequ ... Read More
Author(s): V.B Karsdal*
Insight into the functional processes that underpin central nervous system (CNS) dysfunction in psychiatric disorder is currently being bolstered by neuroscience. An increasing number of potential ... Read More
Author(s): Bjurlin Richard*
In medication research and development, as well as regulatory evaluation, a better biomarker-based assessment of drug safety is required. Identifying drug safety biomarkers such as genes, proteins, mi ... Read More
Author(s): William Maria*
With the failure rate of clinical trials for CNS illnesses reaching all-time low, new strategies are needed to reverse the trend. This paper looks back at the recent history of CNS drug development an ... Read More
Author(s): Khorana Jung*
Parkinson's disease (PD) is the second most prevalent neurodegenerative ailment and is caused by human physiological function. Dopamine agonists, which replicate dopamine's natural activity in ... Read More